Desimar 0,15 mg FC Tablets
PDF Leaflet Revision Date: 07 June 2024
Clinical Summary
Quick overview from the medicine insert
Indication
Oral contraception.
Dosage (summary)
1 tablet daily for 28 days, starting on day 1 of the menstrual cycle.
Special Populations
- Hepatic impairment
- Children and adolescents
- Elderly
Pregnancy & Breastfeeding
Not recommended during pregnancy; may affect breast milk composition.
Key Drug Interactions
- Hydantoins
- Barbiturates
- Rifampicin
- Antibiotics
Contraindications
- Hypersensitivity to components
- Thromboembolic events
- Migraine
- Severe hepatic disease
- Undiagnosed vaginal bleeding
- Pregnancy
Common side effects
- Nausea
- Headache
- Depressive mood
- Breast tenderness
Counselling Points
- Take at the same time daily
- Use barrier method if tablets missed
- Monitor for mood changes
Serious warnings
- Increased risk of thromboembolic events
- Mood changes
- Potential for cervical and breast cancer
Important Disclaimer
The Desimar 0,15 mg FC Tablets professional information leaflet below is the property of Cipla Medpro and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
